Angelique et al. reported that dendritic cells (DCs) transfected with CD133 mRNA (cancer stem cell marker) activated T cells, produced an effective and long-lived immune response, and suppressed the proliferation of CD133+ glioma stem cells (GSCs) and tumor growth in mice (19). The gene discussed is PROM1; the disease is cancer.